本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Revolution Medicines, Inc.

204.86
-0.2500-0.12%
盤後204.50-0.3600-0.18%19:34 EDT
成交量:126.88萬
成交額:2.58億
市值:439.09億
市盈率:-22.96
高:207.00
開:206.98
低:200.24
收:205.11
52周最高:224.31
52周最低:42.18
股本:2.14億
流通股本:1.85億
量比:0.90
換手率:0.69%
股息:- -
股息率:- -
每股收益(TTM):-8.9212
每股收益(LYR):-5.9502
淨資產收益率:-79.09%
總資產收益率:-30.12%
市淨率:16.85
市盈率(LYR):-34.43

資料載入中...

2026/09/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/09/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/09/01

重要事件披露

Form 8-K - Current report
2026/08/31

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/27

重要事件披露

Form 8-K - Current report
2026/08/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/14

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/08/13

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/13

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/08/06

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/06

重要事件披露

Form 8-K - Current report
2026/07/30

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/06/30

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/25

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/22

重要事件披露

Form 8-K - Current report
2026/06/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities